Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

288
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
288
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

743
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
743
Hormonal Regulation01:40

Hormonal Regulation

44.8K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
44.8K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

3.6K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
3.6K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

3.3K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.3K
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

613
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
613

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of patient and partner preconceptional nutraceutical supplementation on the onset of natural pregnancy: a retrospective study.

Revista da Associacao Medica Brasileira (1992)·2026
Same author

Hormonal and metabolic effects of the administration of oral low-dose 17-β-estradiol (0.2 mg) in patients with Functional Hypothalamic Amenorrhea (FHA): A Retrospective Pilot Study.

Fertility and sterility·2026
Same author

Repurposing metformin: is it the new holy grail for longevity?

Maturitas·2026
Same author

FDA safety concerns and menopausal-like symptoms in postmenopausal statin users.

Menopause (New York, N.Y.)·2026
Same author

Ketogenic diet as a therapeutic intervention for biochemical hyperandrogenism in PCOS women with obesity or overweight: a meta-analytic study.

Journal of endocrinological investigation·2026
Same author

From 'polycystic ovary syndrome' to 'polyendocrine metabolic ovarian syndrome': why terminology matters.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2026

Related Experiment Video

Updated: Sep 24, 2025

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

15.6K

Menopause: a cardiometabolic transition.

Rossella E Nappi1, Peter Chedraui2, Irene Lambrinoudaki3

  • 1Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS San Matteo Foundation, Pavia, Italy; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.

The Lancet. Diabetes & Endocrinology
|May 7, 2022
PubMed
Summary

Menopause significantly impacts women's cardiovascular health, increasing risks due to hormonal changes and aging. Early management of risk factors and recognizing female-specific conditions are crucial for preventing heart disease in midlife women.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.0K

Related Experiment Videos

Last Updated: Sep 24, 2025

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

15.6K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

2.0K

Area of Science:

  • Cardiology
  • Endocrinology
  • Women's Health

Background:

  • Menopause marks a critical health transition for women globally.
  • Cardiometabolic changes, including increased fat mass, insulin resistance, and endothelial dysfunction, occur during menopause, exacerbating aging-related cardiovascular disease (CVD) risks.
  • Loss of estrogen protection post-menopause elevates CVD risk, particularly in women with vasomotor symptoms.

Purpose of the Study:

  • To review literature on cardiometabolic changes during midlife (40-65 years).
  • To identify factors predicting cardiovascular disease occurrence in women.
  • To summarize evidence on non-hormonal preventive strategies for cardiometabolic health.

Main Methods:

  • Literature review of experimental and clinical studies.
  • Analysis of factors influencing cardiometabolic health during the menopausal transition.
  • Synthesis of evidence on risk factor management and preventive strategies.

Main Results:

  • Menopausal transition is linked to adverse cardiometabolic changes and increased CVD risk.
  • Traditional CVD risk factors (hypertension, obesity, diabetes, dyslipidemia, smoking) require early management.
  • Female-specific reproductive history factors (e.g., gestational diabetes, premature ovarian insufficiency) can heighten CVD risk.

Conclusions:

  • Understanding and managing cardiometabolic changes during menopause is vital for women's long-term cardiovascular health.
  • Integrated management should address traditional risk factors and female-specific reproductive health history.
  • Preventive non-hormonal strategies play a key role in maintaining cardiometabolic health in midlife women.